Expanding Value Assessment Beyond Drugs

2020-02-26T16:45:13-06:00December 19th, 2019|IVI News, Viewpoints|

Jennifer Bright writes in Morning Consult that while we’ve made progress assessing the value of biopharmaceuticals, more focus is needed to develop bout transparent, patient-centered value assessment methods in healthcare technologies beyond drugs.

Read the full article here.